The APAC glycomics market is expected to grow from US$ 320.16 million in 2022 to US$ 699.78 million by 2028; it is estimated to grow at a CAGR of 13.9% from 2022 to 2028.

By enhancing the characterization of molecules crucial to the development of diseases, glycomics has the potential to pave the way for innovative treatment approaches. It can be a substantial addition to technologies used in genomes and proteomics. Comparative glycomics will be essential for identifying the glycans that cause disease, and studies will provide light on the relationship between clinical outcomes and glycomic anomalies. Immunohistochemistry (IHC), Liquid Chromatography-Mass Spectrometry (LC-MS), and high-throughput fluorescence flow cytometry have long been used to distinguish cell populations using glycoproteins. These are the important technologies utilized to advance glycomics. By separating several glycoprotein isoforms from a single protein species, LC-MS can provide structural details about glycoconjugates. Unbiased surveys of cellular proteomes are now available due to high-throughput MS-based proteomics, and the method is swiftly applied to glycomics. Structural reference databases are quickly emerging to close the gap between the variety and complexity of glycan structures. Identification of disease-related glycoconjugates by LC-MS, which employs antibody-based capture to view glycoconjugate expression with cell-staining or fluorescence, can be used to further assess or validate IHC. Targeting complete cells rather than tissue fragments, immunocytochemistry (ICC) reveals glycoprotein expression patterns at the cellular level utilizing the same imaging techniques as IHC. It will be possible to see new aspects of glycomics, such as a more thorough characterization of metabolic junctions and pathways, by modifying IHC and ICC to concentrate on additional glycoconjugates, such as glycolipids. Tandem or multi-technology procedures, such as MS-IHC, will provide labs with more analytical ability to handle the complexity of glycoconjugates and improve glycoconjugate diagnosis. The clinical applications of glycomics are catching up to those of genomics and proteomics due to the development of new high-throughput methods to study the structure and expression of glycans and ongoing innovation in glycan biomarkers and therapies. Integrating glycomics will revolutionize precision medicine into an extensive omics strategy, providing new information on the interactions between genes, proteins, and glycans. The combination of omics data with digital health platforms has the potential to improve clinical trials and aid in the creation of more complex knowledge of illness among researchers and doctors. Although these and other scientific discoveries are making their way from the lab to the clinic, widespread acceptance of glycomics and personalized medicine will necessitate significant changes in regulatory and reimbursement procedures and legislative privacy laws. Thus, customized healthcare challenges will be met and overcome with the assurance that the research behind glycomic medicine is decent and that the practice of medicine that it informs is evidence-based. So, new tools in glycomics research are expected to drive the market in the coming years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC glycomics market . The APAC glycomics market is expected to grow at a good CAGR during the forecast period.

APAC Glycomics Market Revenue and Forecast to 2028 (US$ Million)

APAC Glycomics Market Segmentation

The APAC glycomics market is segmented based on product, application, end user, and country. Based on product, the APAC glycomics market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment dominated the market in 2022. The enzymes segment is further segmented into glycosidases, glycosyl transferases, sialyltransferases, neuraminidases, and others. The instruments segment is also segmented into mass spectrometers, MALDI-TOF, HPLC, lectin arrays, antibody arrays, and others. The kits segment is categorized into glycan release kits, glycan labeling kits, glycan purification kits, and others. The reagents segment is segmented into oligosaccharides, monosaccharides, glycoproteins, and others.

In terms of application, the APAC glycomics market is segmented into drug discovery and development, diagnostics, immunology, cancer, and others. The drug discovery and development segment dominated the market in 2022. Based on end user, the APAC glycomics market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnology companies segment dominated the market in 2022. Based on country, the APAC glycomics market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. China dominated the market in 2022.

Agilent Technologies, Inc.; Bruker Corporation; MERCK KGaA; New England Biolabs; S-BIO (Sumitomo Bakelite Co., Ltd.); Shimadzu Corporation; Takara Bio Inc.; Thermo Fisher Scientific Inc.; and Waters Corporation are among the leading companies in the APAC glycomics market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Glycomics Market – By Product
1.3.2 APAC Glycomics Market – By Application
1.3.3 APAC Glycomics Market – By End User
1.3.4 APAC Glycomics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Glycomics Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Expert Opinion
5. APAC Glycomics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increased Glycomics Research and Expanding R&D Investments
5.1.2 Rising Use of Glycomics in Various Diseases Leading to Development of New Treatment Processes
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of skilled Professionals
5.3 Market Opportunities
5.3.1 Wide Applications of Glycomics
5.4 Future Trends
5.4.1 New tools in Glycomics Research
5.5 Impact Analysis
6. Glycomics Market– APAC Analysis
6.1 APAC Glycomics Market Revenue Forecast and Analysis
7. APAC Glycomics Market Analysis – By Product
7.1 Overview
7.2 APAC Glycomics Market, By Product 2022 & 2028 (%)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzymes Revenue and Forecast to 2028 (US$ Million)
7.3.3 Glycosidases
7.3.3.1 Overview
7.3.3.2 Glycosidases – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Glycosyltransferases
7.3.4.1 Overview
7.3.4.2 Glycosyltransferases – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Sialyltransferases
7.3.5.1 Overview
7.3.5.2 Sialyltransferases – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Neuraminidases
7.3.6.1 Overview
7.3.6.2 Neuraminidases – Revenue and Forecast to 2028 (US$ Million)
7.3.7 Others
7.3.7.1 Overview
7.3.7.2 Others- Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Mass Spectrometers
7.4.3.1 Overview
7.4.3.2 Mass Spectrometers- Revenue and Forecast to 2028 (US$ Million)
7.4.4 MALDI-TOF
7.4.4.1 Overview
7.4.4.2 MALDI-TOF – Revenue and Forecast to 2028 (US$ Million)
7.4.5 High-Performance Liquid Chromatography (HPLC)
7.4.5.1 Overview
7.4.5.2 High-Performance Liquid Chromatography (HPLC)- Revenue and Forecast to 2028 (US$ Million)
7.4.6 Lectin Arrays
7.4.6.1 Overview
7.4.6.2 Lectin Arrays- Revenue and Forecast to 2028 (US$ Million)
7.4.7 Antibody Arrays
7.4.7.1 Overview
7.4.7.2 Antibody Arrays – Revenue and Forecast to 2028 (US$ Million)
7.4.8 Others
7.4.8.1 Overview
7.4.8.2 Others- Revenue and Forecast to 2028 (US$ Million)
7.5 Kits
7.5.1 Overview
7.5.2 Kits – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Glycan Release Kits
7.5.3.1 Overview
7.5.3.2 Glycan Release Kits – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Glycan Labelling Kits
7.5.4.1 Overview
7.5.4.2 Glycan Labelling Kits – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Glycan Purification Kits
7.5.5.1 Overview
7.5.5.2 Glycan Purification Kits – Revenue and Forecast to 2028 (US$ Million)
7.5.6 Others
7.5.6.1 Overview
7.5.6.2 Others- Revenue and Forecast to 2028 (US$ Million)
7.6 Reagents
7.6.1 Overview
7.6.2 Reagents – Revenue and Forecast to 2028 (US$ Million)
7.6.3 Oligosaccharides
7.6.3.1 Overview
7.6.3.2 Oligosaccharides- Revenue and Forecast to 2028 (US$ Million)
7.6.4 Monosaccharides
7.6.4.1 Overview
7.6.4.2 Monosaccharides – Revenue and Forecast to 2028 (US$ Million)
7.6.5 Glycoproteins
7.6.5.1 Overview
7.6.5.2 Glycoproteins – Revenue and Forecast to 2028 (US$ Million)
7.6.6 Others
7.6.6.1 Overview
7.6.6.2 Others- Revenue and Forecast to 2028 (US$ Million)
8. APAC Glycomics Market Analysis – By Application
8.1 Overview
8.2 APAC Glycomics Market, By Application 2022 & 2028 (%)
8.3 Drug Discovery and Development
8.3.1 Overview
8.3.2 Drug Discovery and Development – Market Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostics
8.4.1 Overview
8.4.2 Diagnostics – Market Revenue and Forecast to 2028 (US$ Million)
8.5 Immunology
8.5.1 Overview
8.5.2 Immunology – Market Revenue and Forecast to 2028 (US$ Million)
8.6 Cancer
8.6.1 Overview
8.6.2 Cancer – Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others – Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Glycomics Market Analysis – By End User
9.1 Overview
9.2 APAC Glycomics Market, By End User 2022 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies – Market Revenue And Forecasts To 2028 (US$ Million)
9.4 Contract Research Organizations
9.4.1 Overview
9.4.2 Contract Research Organizations – Market Revenue And Forecasts To 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes – Market Revenue And Forecasts To 2028 (US$ Million)
10. APAC Glycomics Market – Country Analysis
10.1 APAC Glycomics Market Revenue and Forecasts To 2028
10.1.1 Overview
10.1.3 APAC: Glycomics Market Revenue and Forecasts to 2028, By Country (%)
10.1.3.1 China: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.1.1 Overview
10.1.3.1.2 China: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.1.3 China: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.1.3.1 China: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
10.1.3.1.3.2 China: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
10.1.3.1.3.3 China: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
10.1.3.1.3.4 China: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
10.1.3.1.4 China: Glycomics Market, by Application, 2019–2028 (US$ Million)
10.1.3.1.5 China: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.3.2 Japan: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.2.1 Overview
10.1.3.2.2 Japan: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.2.3 Japan: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.2.3.1 Japan: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
10.1.3.2.3.2 Japan: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
10.1.3.2.3.3 Japan: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
10.1.3.2.3.4 Japan: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
10.1.3.2.4 Japan: Glycomics Market, by Application, 2019–2028 (US$ Million)
10.1.3.2.5 Japan: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.3.3 India Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.3.1 Overview
10.1.3.3.2 India: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.3.3 India: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.3.3.1 India: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
10.1.3.3.3.2 India: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
10.1.3.3.3.3 India: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
10.1.3.3.3.4 India: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
10.1.3.3.4 India: Glycomics Market, by Application, 2019–2028 (US$ Million)
10.1.3.3.5 India: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.3.4 South Korea: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.4.1 Overview
10.1.3.4.2 South Korea: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.4.3 South Korea: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.4.3.1 South Korea: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
10.1.3.4.3.2 South Korea: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
10.1.3.4.3.3 South Korea: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
10.1.3.4.3.4 South Korea: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
10.1.3.4.4 South Korea: Glycomics Market, by Application, 2019–2028 (US$ Million)
10.1.3.4.5 South Korea: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.3.5 Australia: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.5.1 Overview
10.1.3.5.2 Australia: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.3.5.3 Australia: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.5.3.1 Australia: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
10.1.3.5.3.2 Australia: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
10.1.3.5.3.3 Australia: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
10.1.3.5.3.4 Australia: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
10.1.3.5.4 Australia: Glycomics Market, by Application, 2019–2028 (US$ Million)
10.1.3.5.5 Australia: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.3.6 Rest of APAC: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.6.1 Overview
10.1.3.6.2 Rest of APAC: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3.6.3 Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.3.6.3.1 Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
10.1.3.6.3.2 Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
10.1.3.6.3.3 Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
10.1.3.6.3.4 Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
10.1.3.6.4 Rest of APAC: Glycomics Market, by Application, 2019–2028 (US$ Million)
10.1.3.6.5 Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 MERCK KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Agilent Technologies, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 New England Biolabs
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Waters Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bruker Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Takara Bio Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 S-BIO (Sumitomo Bakelite Co., Ltd.)
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Shimadzu Corporation
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Glycomics Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. China: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 3. China: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
Table 4. China: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
Table 5. China: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
Table 6. China: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
Table 7. China: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. China: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 9. Japan: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 10. Japan: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
Table 11. Japan: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
Table 12. Japan: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
Table 13. Japan: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
Table 14. Japan: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Japan: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 16. India: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 17. India: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
Table 18. India: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
Table 19. India: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
Table 20. India: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
Table 21. India: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 22. India: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 23. South Korea: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 24. South Korea: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
Table 25. South Korea: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
Table 26. South Korea: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
Table 27. South Korea: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
Table 28. South Korea: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 29. South Korea: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 30. Australia: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 31. Australia: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
Table 32. Australia: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
Table 33. Australia: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
Table 34. Australia: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
Table 35. Australia: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 36. Australia: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 37. Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 38. Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Enzymes (US$ Million)
Table 39. Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Instruments (US$ Million)
Table 40. Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Kits (US$ Million)
Table 41. Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By Reagents (US$ Million)
Table 42. Rest of APAC: Glycomics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of APAC: Glycomics Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 44. Organic Developments in the Glycomics Market
Table 45. Inorganic Developments in the Glycomics Market
Table 46. Glossary of Terms
 
 

LIST OF FIGURES

Figure 1. APAC Glycomics Market Segmentation
Figure 2. APAC Glycomics Market, By Country
Figure 3. APAC Glycomics Market Overview
Figure 4. APAC Glycomics Market, By Product
Figure 5. APAC Glycomics Market, By Country
Figure 6. APAC: PEST Analysis
Figure 7. APAC Glycomics Market Impact Analysis of Driver and Restraints
Figure 8. APAC Glycomics Market – Revenue Forecast and Analysis
Figure 9. APAC Glycomics Market, by Product 2022 & 2028 (%)
Figure 10. APAC Enzymes Revenue and Forecasts to 2028 (US$ Million)
Figure 11. APAC Glycosidases – Revenue and Forecasts to 2028 (US$ Million)
Figure 12. APAC Glycosyltransferases – Revenue and Forecasts to 2028 (US$ Million)
Figure 13. APAC Sialyltransferases – Revenue and Forecasts to 2028 (US$ Million)
Figure 14. APAC Neuraminidases – Revenue and Forecasts to 2028 (US$ Million)
Figure 15. APAC Others – Revenue and Forecasts to 2028 (US$ Million)
Figure 16. APAC Instruments – Revenue and Forecasts to 2028 (US$ Million)
Figure 17. APAC Mass Spectrometers – Revenue and Forecasts to 2028 (US$ Million)
Figure 18. APAC MALDI-TOF – Revenue and Forecasts to 2028 (US$ Million)
Figure 19. APAC High-Performance Liquid Chromatography (HPLC)- Revenue and Forecasts to 2028 (US$ Million)
Figure 20. APAC Lectin Arrays – Revenue and Forecasts to 2028 (US$ Million)
Figure 21. APAC Antibody Arrays – Revenue and Forecasts to 2028 (US$ Million)
Figure 22. APAC Others – Revenue and Forecasts to 2028 (US$ Million)
Figure 23. APAC Kits – Revenue and Forecasts to 2028 (US$ Million)
Figure 24. APAC Glycan Release Kits – Revenue and Forecasts to 2028 (US$ Million)
Figure 25. APAC Glycan Labelling Kits – Revenue and Forecasts to 2028 (US$ Million)
Figure 26. APAC Glycan Purification Kits – Revenue and Forecasts to 2028 (US$ Million)
Figure 27. APAC Others – Revenue and Forecasts to 2028 (US$ Million)
Figure 28. APAC Reagents – Revenue and Forecasts to 2028 (US$ Million)
Figure 29. APAC Oligosaccharides – Revenue and Forecasts to 2028 (US$ Million)
Figure 30. APAC Monosaccharides – Revenue and Forecasts to 2028 (US$ Million)
Figure 31. APAC Glycoproteins – Revenue and Forecasts to 2028 (US$ Million)
Figure 32. APAC Others – Revenue and Forecasts to 2028 (US$ Million)
Figure 33. APAC Glycomics Market, by Application 2022 & 2028 (%)
Figure 34. APAC Drug Discovery and Development – Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. APAC Diagnostics – Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. APAC Immunology – Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. APAC Cancer – Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. APAC Others – Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. APAC Glycomics Market, by End User 2022 & 2028 (%)
Figure 40. APAC Pharmaceutical and Biotechnology Companies – Market Revenue And Forecasts To 2028 (US$ Million)
Figure 41. APAC Contract Research Organizations – Market Revenue And Forecasts To 2028 (US$ Million)
Figure 42. APAC Academic and Research Institutes – Market Revenue And Forecasts To 2028 (US$ Million)
Figure 43. APAC Glycomics Market Overview, by Country (2022)
Figure 44. APAC: Glycomics Market Revenue and Forecasts to 2028, By Country (%)
Figure 45. China: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46. Japan: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 47. India: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 48. South Korea: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 49. Australia: Glycomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 50. Rest of APAC: Glycomics Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC glycomics market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the APAC glycomics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the glycomics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Asia-Pacific Glycomics Market

● Agilent Technologies, Inc.
● Bruker Corporation
● MERCK KGaA
● New England Biolabs
● S-BIO (Sumitomo Bakelite Co., Ltd.)
● Shimadzu Corporation
● Takara Bio Inc.
● Thermo Fisher Scientific Inc.    
● Waters Corporation    

At 4.0% CAGR, the APAC Epirubicin Market is speculated to be worth US$ 37,447.28 thousand by 2028, says The Insight Partners

According to The Insight Partners’ research, the APAC epirubicin market was valued at US$ 29,679.40 thousand in 2022 and is expected to reach US$ 37,447.28 thousand by 2028, registering an annual growth rate of 4.0% from 2022 to 2028. Increasing awareness regarding cancer and rising prevalence of cancer are the critical factors attributed to the market expansion.

Cancer is the second leading cause of mortality across the region. Furthermore, National Cancer Institute (NCI) funded researchers working at the National Institute of Health (NIH) campus across the region are seeking ways to address breast cancer more effectively. Some research is fundamental, exploring questions as diverse as the biological foundations of cancer and the social factors that affect cancer risk. Several research efforts have taken place in recent years by NCI. For instance, the Breast Specialized Programs of Research Excellence (Breast SPOREs) are designed to move basic scientific findings into clinical settings quickly. The Breast SPOREs support the development of new therapies, technologies, and studies for a better understanding of tumor resistance, diagnosis, prognosis, screening, prevention, and treatment of breast cancer. Secondly, the NCI Cancer Intervention and Surveillance Modeling Network (CISNET) focuses using modeling to improve knowledge to prevent, early detection, screening, and treatment affect breast cancer results. Ongoing programs at NCI help prevention and early detection research in different cancers. The factors mentioned above would fuel the growth of the epirubicin market across the region.

On the contrary, elevated risk of adverse effects due to epirubicin hurdles the growth of APAC epirubicin market.

Based on dosage, the APAC epirubicin market is segmented into 10mg/vial, 50mg/vial, 100mg/vial, and 200mg/vial. The 50mg/vial segment held 38.7% market share in 2022, amassing US$ 11,488.46 thousand. It is projected to garner US$ 14,700.85 thousand by 2028 to expand at 4.2% CAGR during 2022–2028. Based on application, the APAC epirubicin market is segmented into breast cancer, liver cancer, bladder cancer, and others. The breast cancer segment held 72.2% market share in 2022, amassing US$ 21,414.09 thousand. It is projected to garner US$ 27,214.15 thousand by 2028 to expand at 4.1% CAGR during 2022–2028. Based on distribution channel, the APAC epirubicin market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held 62.4% market share in 2022, amassing US$ 18,522.00 thousand. It is projected to garner US$ 23,923.37 thousand by 2028 to expand at 4.4% CAGR during 2022–2028. Based on country, the APAC epirubicin market has been categorized into China, India, Japan, South Korea, Australia, and rest of APAC. Our regional analysis states that China captured 38.2% market share in 2022. It was assessed at US$ 11,323.92 thousand in 2022 and is likely to hit US$ 14,639.08 thousand by 2028, exhibiting a CAGR of 4.4% during the forecast period. Key players dominating the APAC epirubicin market are Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Miracalus Pharma Pvt. Ltd., Mylan N.V., Pfizer Inc., Salius Pharma Pvt Ltd, and Teva Pharmaceutical Industries Ltd. among others.